Your search for oral corticosteroids returned 10 results

Patients with normal adrenal function are largely able to eliminate the use of oral corticosteroids or achieve a daily dose of 5 mg or less.

Patients with asthma who depend on oral corticosteroids (OCS) may be able to reduce the dependence or eliminate the use of OCS altogether with benralizumab.

Long-term treatment of oral corticosteroid (OCS)-dependent asthma with dupilumab has shown efficacy in weaning off OCS while improving lung function.

The submission was based on data from the double-blind, placebo-controlled VOYAGE trial.

The BLA submission is supported by data from the PATHFINDER clinical program.

Active eosinophilic esophagitis appears to be associated with lower lung function and increased asthma severity in children with comorbid asthma.

The American Thoracic Society has released a new clinical practice guideline on the pharmacologic management of chronic obstructive pulmonary disease.

The FDA has approved Zeposia® (ozanimod) for moderately to severely active ulcerative colitis in adults.

Ascorbic acid level testing confirmed severe deficiency (<0.1mg/dL).

Previous studies have shown that GLP-1RAs demonstrate a protective effect by attenuating bronchial hyperresponsiveness.